Indivior Pharmaceuticals, Inc. (INDV) FY2026 Q3 Balance Sheet
Published Source: Form 10-Q on SEC EDGAR filed (opens in a new tab)
Balance Sheet
Swipe to see the full flow
Chart details
Indivior Pharmaceuticals, Inc. (INDV) FY2026 Q3 Balance Sheet
Balance sheet as of 2026-09-30. The chart shows assets, liabilities and equity at that date.
- Assets
- 1,332,000,000 US dollars
- Current assets
- 800,000,000 US dollars
- Non-current assets
- 532,000,000 US dollars
- Liabilities
- 1,392,000,000 US dollars
- Current liabilities
- 1,301,000,000 US dollars
- Non-current liabilities
- 91,000,000 US dollars
- Shareholders' deficit
- negative 60,000,000 US dollars
- Cash and cash equivalents
- 305,000,000 US dollars
- Accounts receivable, net of allowances of $3 (2026) and $4 (2025)
- 273,000,000 US dollars
- Inventories
- 149,000,000 US dollars
- Other current assets
- 40,000,000 US dollars
- Prepaid expenses
- 21,000,000 US dollars
- Current tax receivable
- 13,000,000 US dollars
- Deferred tax assets
- 288,000,000 US dollars
- Property, plant and equipment, net
- 175,000,000 US dollars
- Long-term investments
- 27,000,000 US dollars
- Other noncurrent assets
- 27,000,000 US dollars
- Operating lease right of use assets, net
- 12,000,000 US dollars
- Goodwill and other intangible assets, net
- 2,000,000 US dollars
- Accrued rebates and product returns
- 548,000,000 US dollars
- Current portion of long-term debt
- 488,000,000 US dollars
- Accounts payable and accrued expenses
- 181,000,000 US dollars
- Income taxes payable
- 63,000,000 US dollars
- Accrued litigation settlement expenses, current
- 14,000,000 US dollars
- Operating lease liabilities, current
- 7,000,000 US dollars
- Accrued litigation settlement expenses, noncurrent
- 42,000,000 US dollars
- Other noncurrent liabilities
- 42,000,000 US dollars
- Operating lease liabilities, noncurrent
- 6,000,000 US dollars
- Long-term debt, less current portion
- 0 US dollars
- Additional paid-in capital
- 163,000,000 US dollars
- Common stock, par value $0.001 per share (2026) and $0.50 per share (2025). Issued shares: 118 (2026) and 125 (2025)
- 0 US dollars
- Accumulated deficit
- negative 197,000,000 US dollars
- Accumulated other comprehensive loss
- negative 26,000,000 US dollars
Chart connections
- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.
- The filed current assets lines add up to $801.00 M and the current assets total is $800.00 M; the $1.00 M difference is within the rounding of the filed amounts.
- The filed non-current assets lines add up to $531.00 M and the non-current assets total is $532.00 M; the $1.00 M difference is within the rounding of the filed amounts.
- The filed non-current liabilities lines add up to $90.00 M and the non-current liabilities total is $91.00 M; the $1.00 M difference is within the rounding of the filed amounts.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
